UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 11
November-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2411129


Registration ID:
550264

Page Number

b253-b263

Share This Article


Jetir RMS

Title

Early Detection of Schizophrenia Disease Using Blood Plasma Biomarkers with Deep Learning

Abstract

The development of amyloid-based biomarkers and diagnostic tests for Schizophrenia (SD) marks a significant advancement in diagnostic tools. However, two key challenges remain: amyloid-based biomarkers offer only a limited view of the disease's progression, and they fail to detect SD before substantial amyloid-beta build-up in the brain. This study seeks to overcome these challenges by establishing blood-based, non-amyloid biomarkers for early SD detection. Blood is an appealing medium due to its accessibility and cost-effectiveness. Leveraging machine learning (ML), particularly transformers, we can develop multi-variable models that discern complex patterns within large datasets. Through innovative feature selection and assessment, we identified five promising non-amyloid protein panels for early SD detection. Notably, a biomarker profile composed of A2M, ApoE, BNP, Eot3, RAGE, and SGOT showed strong potential for early-stage SD detection. Models built with these panels achieved a sensitivity of over 99.28%, specificity above 99.73%, and an area under the receiver operating characteristic curve (AUC) of at least 98.87% in the prodromal stage, with even higher accuracy in later stages. By contrast, existing ML models have shown limited success in early SD detection, indicating that previous protein panels may not be optimal for early-phase diagnosis. These findings highlight the potential of non-amyloid biomarkers for early SD detection, offering a viable alternative to traditional amyloid-based diagnostics.

Key Words

Schizophrenia Disease, Blood Plasma Biomarkers, Bi-Directional Attention Mechanism, Deep Learning

Cite This Article

"Early Detection of Schizophrenia Disease Using Blood Plasma Biomarkers with Deep Learning", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 11, page no.b253-b263, November-2024, Available :http://www.jetir.org/papers/JETIR2411129.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Early Detection of Schizophrenia Disease Using Blood Plasma Biomarkers with Deep Learning", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 11, page no. ppb253-b263, November-2024, Available at : http://www.jetir.org/papers/JETIR2411129.pdf

Publication Details

Published Paper ID: JETIR2411129
Registration ID: 550264
Published In: Volume 11 | Issue 11 | Year November-2024
DOI (Digital Object Identifier):
Page No: b253-b263
Country: Bhopal, Madhya Pradesh, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000108

Print This Page

Current Call For Paper

Jetir RMS